Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial

BACKGROUND: There are presently no available therapeutic options for peanut-allergic patients. OBJECTIVE: To investigate the safety, efficacy, and immunologic effects of peanut sublingual immunotherapy (SLIT). METHODS: After a baseline oral food challenge (OFC) of up to 2g of peanut powder (~50% pro...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fleischer, David M., Burks, A. Wesley, Vickery, Brian P., Scurlock, Amy M., Wood, Robert A., Jones, Stacie M., Sicherer, Scott H., Liu, Andrew H., Stablein, Donald, Henning, Alice K., Mayer, Lloyd, Lindblad, Robert, Plaut, Marshall, Sampson, Hugh A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3550002/
https://ncbi.nlm.nih.gov/pubmed/23265698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2012.11.011
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky